XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.20.2

Net Income (Loss) Attributable to Shareholders of Crawford & Company per Common Share | 6 Months Ended
--- | ---
Jun. 30, 2020
Earnings Per Share [Abstract] |
Net Income (Loss) Attributable to Shareholders of Crawford & Company per Common Share | 7. Net Income (Loss) Attributable to Shareholders of Crawford & Company per Common Share The Company computes earnings per share of its non-voting Class A Common Stock ("CRD-A") and voting Class B Common Stock ("CRD-B") using the two-class method, which allocates the undistributed earnings (loss) in each period to each class on a proportionate basis. The Company's Board of Directors has the right, but not the obligation, to declare higher dividends on the CRD-A shares than on the CRD-B shares, subject to certain limitations. In periods when the dividend is the same for CRD-A and CRD-B or when no dividends are declared or paid to either class, the two-class method generally will yield the same earnings (loss) per share for CRD-A and CRD-B. During the second quarter of 2020, the Board of Directors declared the same dividend on CRD-A and CRD-B, while during the first quarter of 2020, and the first two quarters of 2019, the Board of Directors declared a higher dividend on CRD-A than on CRD-B. The computations of basic net income (loss) attributable to shareholders of Crawford & Company per common share were as follows:
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, 2020 |  |  | June 30, 2019 |  |  | June 30, 2020 |  |  | June 30, 2019 |
(in thousands, except per share amounts) |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |
Earnings (loss) per share - basic: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allocation of undistributed earnings (loss) |  | $ | 2,479 |  |  | $ | 1,828 |  |  | $ | (384 | ) |  | $ | (287 | ) |  | $ | (5,960 | ) |  | $ | (4,400 | ) |  | $ | 1,229 |  |  | $ | 927 |
Dividends paid |  |  | 916 |  |  |  | 675 |  |  |  | 2,161 |  |  |  | 1,152 |  |  |  | 3,055 |  |  |  | 1,804 |  |  |  | 4,291 |  |  |  | 2,304 |
Net income (loss) attributable to common shareholders, basic |  | $ | 3,395 |  |  | $ | 2,503 |  |  | $ | 1,777 |  |  | $ | 865 |  |  | $ | (2,905 | ) |  | $ | (2,596 | ) |  | $ | 5,520 |  |  | $ | 3,231 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding, basic |  |  | 30,521 |  |  |  | 22,510 |  |  |  | 30,799 |  |  |  | 23,021 |  |  |  | 30,541 |  |  |  | 22,544 |  |  |  | 30,729 |  |  |  | 23,193 |
Earnings (loss) per share - basic |  |  | 0.11 |  |  |  | 0.11 |  |  |  | 0.06 |  |  |  | 0.04 |  |  |  | (0.10 | ) |  |  | (0.12 | ) |  |  | 0.18 |  |  |  | 0.14 |
The computations of diluted net income (loss) attributable to shareholders of Crawford & Company per common share were as follows:
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, 2020 |  |  | June 30, 2019 |  |  | June 30, 2020 |  |  | June 30, 2019 |
(in thousands, except per share amounts) |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |
Earnings (loss) per share - diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allocation of undistributed earnings (loss) |  | $ | 2,479 |  |  | $ | 1,828 |  |  | $ | (385 | ) |  | $ | (286 | ) |  | $ | (5,960 | ) |  | $ | (4,400 | ) |  | $ | 1,235 |  |  | $ | 921 |
Dividends paid |  |  | 916 |  |  |  | 675 |  |  |  | 2,161 |  |  |  | 1,152 |  |  |  | 3,055 |  |  |  | 1,804 |  |  |  | 4,291 |  |  |  | 2,304 |
Net income (loss) attributable to common shareholders, diluted |  | $ | 3,395 |  |  | $ | 2,503 |  |  | $ | 1,776 |  |  | $ | 866 |  |  | $ | (2,905 | ) |  | $ | (2,596 | ) |  | $ | 5,526 |  |  | $ | 3,225 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding, basic |  |  | 30,521 |  |  |  | 22,510 |  |  |  | 30,799 |  |  |  | 23,021 |  |  |  | 30,541 |  |  |  | 22,544 |  |  |  | 30,729 |  |  |  | 23,193 |
Weighted-average effect of dilutive securities |  |  | 169 |  |  |  | — |  |  |  | 314 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 381 |  |  |  | — |
Weighted-average common shares outstanding, diluted |  |  | 30,690 |  |  |  | 22,510 |  |  |  | 31,113 |  |  |  | 23,021 |  |  |  | 30,541 |  |  |  | 22,544 |  |  |  | 31,110 |  |  |  | 23,193 |
Earnings (loss) per share - diluted |  |  | 0.11 |  |  |  | 0.11 |  |  |  | 0.06 |  |  |  | 0.04 |  |  |  | (0.10 | ) |  |  | (0.12 | ) |  |  | 0.18 |  |  |  | 0.14 |
Listed below are the shares excluded from the denominator in the preceding computation of diluted earnings (loss) per share for CRD-A because their inclusion would have been antidilutive:
|  | Three Months Ended |  |  | Six Months Ended |
(in thousands) |  | June 30, 2020 |  |  | June 30, 2019 |  |  | June 30, 2020 |  |  | June 30, 2019 |
Shares underlying stock options excluded |  |  | 2,011 |  |  |  | 1,585 |  |  |  | 1,962 |  |  |  | 1,439 |
Performance stock grants excluded because performance conditions have not been met (1) |  |  | 1,289 |  |  |  | 1,111 |  |  |  | 1,125 |  |  |  | 1,018 |
(1) | Compensation cost is recognized for these performance stock grants based on expected achievement rates; however, no consideration is given to these performance stock grants when calculating diluted earnings per share until the performance measurements have been achieved.
The following table details shares issued during the three and six months ended June 30, 2020 and 2019. These shares are included from their dates of issuance in the weighted-average common shares used to compute basic and diluted earnings (loss) per share for CRD-A in the table above. There were no shares of CRD-B issued during any of these periods.
|  | Three Months Ended |  |  | Six Months Ended |
(in thousands) |  | June 30, 2020 |  |  | June 30, 2019 |  |  | June 30, 2020 |  |  | June 30, 2019 |
CRD-A issued under Non-Employee Director Stock Plan |  |  | 4 |  |  |  | 9 |  |  |  | 67 |  |  |  | 85 |
CRD-A issued under the U.K. ShareSave Scheme |  |  | — |  |  |  | 257 |  |  |  | 1 |  |  |  | 266 |
CRD-A issued under Executive Stock Bonus Plan |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 30 |
CRD-A issued under 2016 Omnibus Stock and Incentive Plan |  |  | — |  |  |  | 59 |  |  |  | — |  |  |  | 59 |
The Company's share repurchase authorization, approved in July 2017 (the "2017 Repurchase Authorization"), provided the Company with the ability to repurchase up to 2,000,000 shares of CRD-A or CRD-B (or both). The 2017 Repurchase Authorization was terminated on May 8, 2019. Effective May 9, 2019, the Company's Board of Directors authorized the repurchase of up to 2,000,000 shares of CRD-A or CRD-B (or a combination of the two) through December 31, 2020 (the "2019 Repurchase Authorization"). Under the 2019 Repurchase Authorization, repurchases may be made for cash, in the open market or privately negotiated transactions at such times and for such prices as management deems appropriate, subject to applicable contractual and regulatory restrictions. At June 30, 2020, the Company had remaining authorization to repurchase 642,097 shares under the 2019 Repurchase Authorization. During the three months ended June 30, 2020, the Company did not repurchase shares of CRD-A or CRD-B. During the three months ended June 30, 2019, the Company repurchased 280,079 shares of CRD-A and 72,351 shares of CRD-B at an average cost of $9.07 and $8.81 respectively. During the six months ended June 30, 2020, the Company repurchased 155,351 shares of CRD-A and 161,459 shares of CRD-B at an average cost of $8.42 for each share. During the six months ended June 30, 2019, the Company repurchased 701,506 shares of CRD-A and 1,449,240 shares of CRD-B at an average cost of $9.11 for each share, of which 421,427 shares of CRD-A and 1,376,889 shares of CRD-B were purchased pursuant to a stock purchase agreement authorized by the Board of Directors separate from the 2017 Repurchase Authorization and the 2019 Repurchase Authorization.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration